This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Jan 13;352(2):200-1; author reply 200-1.

doi: 10.1056/NEJM200501133520218.

Chemotherapy for advanced prostate cancer

PMID: 15647586
DOI: 10.1056/NEJM200501133520218

Comment

Chemotherapy for advanced prostate cancer

Chadi Nabhan. N Engl J Med. 2005.

. 2005 Jan 13;352(2):200-1; author reply 200-1.

doi: 10.1056/NEJM200501133520218.

Author

PMID: 15647586
DOI: 10.1056/NEJM200501133520218

No abstract available

PubMed Disclaimer

Comment on

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.
Petrylak DP, Tangen CM, Hussain MH, Lara PN Jr, Jones JA, Taplin ME, Burch PA, Berry D, Moinpour C, Kohli M, Benson MC, Small EJ, Raghavan D, Crawford ED. Petrylak DP, et al. N Engl J Med. 2004 Oct 7;351(15):1513-20. doi: 10.1056/NEJMoa041318. N Engl J Med. 2004. PMID: 15470214 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information